Clinical Trial Update: Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage [Phase 1]

View source ↗

Summary

Phase 1 trial of PNEUMOSTEM®, a mesenchymal stromal cell therapy, in premature infants with intraventricular hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraventricular Hemorrhage

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Samsung Medical Center | Conditions: Mesenchymal Stromal Cells | Phase 1 | Status: COMPLETED